Waypoint Bio

Private

New York-based AI-native biotech using spatial pooled screening and computer vision to design in vivo CAR T therapies for solid tumors. Lead program WAY-103. Founded 2021. CTO Patrick Kaifosh previously at CTRL-Labs and Meta Reality Labs.

Founders Xinchen Wang

CEO Xinchen Wang

Company

Founded

2021

Headquarters

New York, USA

Financials

Total Funding

$35M

Sectors

Artificial Intelligence Healthtech Biotech

waypointbio.com

Funding History

2 rounds

Series A Jun 1, 2026

$20M

Amplify Partners (Lead) General Catalyst Time BioVentures Mitsui Global Investments Lux Capital Hummingbird Ventures

Seed Jun 1, 2024

$15M

Lux Capital (Lead) Hummingbird Ventures Amplify Partners

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.